Ningxia Zhongke Biotechnology Co (SHSE:600165) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600165 Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
53 GF Score
Price ¥2.43
GF Value ¥2.77
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ningxia Zhongke Biotechnology Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Ningxia Zhongke Biotechnology Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:600165 vs LIN, SHW, ECL: Margin of Safety % (DCF FCF Based) Comparison

For the Specialty Chemicals subindustry, Ningxia Zhongke Biotechnology Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ningxia Zhongke Biotechnology Co Margin of Safety % (DCF FCF Based) vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ningxia Zhongke Biotechnology Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Ningxia Zhongke Biotechnology Co's Margin of Safety % (DCF FCF Based) falls into.


SHSE:600165
53GF Score
Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?

Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be undervalued. The current stock price of ¥2.43 is trading 12.3% below its estimated GF Value™ of ¥2.77. GuruFocus considers Ningxia Zhongke Biotechnology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600165:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥2.77 vs. price of ¥2.43 (12.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ningxia Zhongke Biotechnology Co Business Description

Address Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
53GF Score

Get the complete analysis for SHSE:600165

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.43
Price
¥2.77
GF Value